🟠 Moderate Evidence
Melatonin, best known as a hormone regulating sleep-wake cycles, functions as a potent antioxidant in multiple tissues beyond the brain and gastrointestinal system. Recent mechanistic research suggests that melatonin may protect skeletal muscle health through mitochondrial signalling pathways, though human clinical evidence remains limited. This emerging understanding has implications for age-related muscle loss, though experts caution against premature supplementation protocols.
Key takeaways
- Melatonin acts as an antioxidant in brain, gut, and skeletal muscle tissue through mitochondrial mechanisms
- Animal studies show melatonin accumulates in muscle mitochondria and may preserve their size and function
- The proposed pathway involves activation of SIRT1/PGC-1α signalling, critical for mitochondrial biogenesis
- Clinical evidence in humans remains preliminary; supplementation protocols for muscle health are not yet established
Melatonin’s proposed antioxidant pathways in skeletal muscle
Mechanistic actions targeting mitochondrial function and sarcopenia prevention
Source: Mechanistic pathway analysis | Georgian Medical Journal News
How melatonin protects muscle at the mitochondrial level
Melatonin is synthesized endogenously in the mitochondria of multiple cell types, where it functions as a free-radical scavenger. The hormone’s antioxidant capacity in the brain and gastrointestinal tract is well-established, but emerging evidence suggests an analogous protective role in skeletal muscle. Animal research indicates that melatonin accumulates specifically in muscle mitochondria—demonstrated in rat gastrocnemius muscle studies—where it helps preserve both mitochondrial structure and function during metabolic stress.
The primary proposed mechanism involves activation of the SIRT1/PGC-1α signalling pathway, which regulates nuclear respiratory factors (NRF1 and NRF2). This cascade stimulates the production of new mitochondria and enhances the expression of antioxidant enzymes, including catalase (CAT). For ageing populations at risk of sarcopenia—age-related muscle loss—mitochondrial dysfunction is a central pathological feature. Improving mitochondrial number and function therefore represents a critical intervention target, alongside maintaining contractile protein turnover and neuromuscular junction integrity.
Animal evidence and mechanism, but limited human data
Preclinical studies in rodents support the mechanistic plausibility of melatonin’s muscle-protective effects. Research on rat calf muscle demonstrates melatonin’s capacity to preserve mitochondrial size and preserve function when animals are subjected to conditions modelling age-related decline or oxidative stress. However, these findings remain in the animal model phase and have not yet translated into robust human clinical trials.
Experts emphasize that while the theoretical basis is sound—melatonin is a naturally occurring mitochondrial metabolite with documented antioxidant activity—translating this into evidence-based supplementation protocols requires human phase II and phase III randomized controlled trials. Clinical Updates on muscle health interventions typically focus on proven modalities such as resistance training and adequate protein intake, which have strong human evidence. Melatonin supplementation for muscle preservation, though biologically plausible, remains in the investigational stage.
Melatonin accumulates in skeletal muscle mitochondria and may preserve their size and function through SIRT1/PGC-1α-mediated mitochondrial biogenesis, a mechanism theoretically relevant to sarcopenia prevention in ageing populations.
— Mechanistic pathway analysis, preclinical evidence base
Implications for age-related muscle loss and beyond
Sarcopenia—progressive loss of muscle mass and strength with advancing age—is a major driver of disability, falls, and loss of independence in older adults. Current prevention strategies emphasize resistance exercise and adequate protein intake, both supported by strong evidence. The emerging understanding of melatonin’s mitochondrial role adds a potential biological mechanism by which endogenous melatonin production may contribute to muscle health; however, whether exogenous supplementation improves clinical outcomes remains unproven.
The proposed pathways offer theoretical promise for future research. If human trials demonstrate efficacy, melatonin supplementation might complement existing sarcopenia prevention strategies, particularly for individuals with documented circulating melatonin deficiency or mitochondrial dysfunction. For now, the evidence supports maintaining adequate sleep (which optimizes endogenous melatonin production), engaging in regular resistance training, and ensuring sufficient protein intake—all established pillars of muscle health in older age.
What this means
Frequently asked questions
Should I take melatonin supplements to preserve muscle mass?
Not on current evidence. While melatonin’s antioxidant role in muscle mitochondria is theoretically plausible based on animal studies, there is no established human clinical evidence that melatonin supplementation prevents or reverses muscle loss. Proven interventions—resistance training, adequate protein, and adequate sleep—remain the foundation of muscle health in older age.
Does melatonin have any established role in muscle health research?
Melatonin is recognized as an endogenous mitochondrial antioxidant with documented roles in brain and gut health. Its potential role in skeletal muscle is based on mechanistic preclinical research showing that melatonin accumulates in muscle mitochondria and may preserve their function; however, human clinical efficacy trials are lacking.
What is sarcopenia and how is it currently prevented?
Sarcopenia is age-related progressive loss of muscle mass and strength, a major driver of disability in older adults. Current evidence-based prevention relies on regular resistance exercise, adequate protein intake (typically 1.0–1.2 g/kg body weight daily), and maintenance of overall physical activity and sleep quality.
As the global population ages, understanding mitochondrial dysfunction in muscle represents a critical research frontier. The emerging role of endogenous melatonin in protecting mitochondrial health offers a biologically plausible mechanism worth investigating in rigorous human trials. Should clinical evidence eventually support melatonin supplementation for sarcopenia prevention, it could provide a complementary tool for managing age-related muscle loss. For now, clinicians and patients should rely on established clinical updates and proven modalities, while remaining attentive to results from future human trials.
Source: Mechanistic pathway analysis of melatonin and skeletal muscle health, based on preclinical evidence | Georgian Medical Journal News
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
